Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Anticonvulsant mood stabilizers, antipsychotic drugs and the insulin resistance syndrome

Trial Profile

Anticonvulsant mood stabilizers, antipsychotic drugs and the insulin resistance syndrome

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Dec 2016

At a glance

  • Drugs Antipsychotics; Aripiprazole; Mood stabilisers; Ziprasidone
  • Indications Bipolar disorders; Schizoaffective disorder; Schizophrenia
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Jan 2009 Status changed from suspended to completed, based on information from ClinicalTrials.gov.
    • 12 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Jun 2008 Pfizer reported as trial affiliate by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top